Early Phase Strategy Specializes in Phase 1 and Phase 2 strategy, first-in-human trials, and proof-of-concept planning for development-stage pharma and biotech; accelerates timelines with senior-level advisory and hands-on IND planning and FDA interactions.

Regulatory Excellence Offers end-to-end regulatory support including IND planning, FDA meetings, and regulatory submissions across therapeutic areas, enabling faster approvals and smoother agency engagement.

Tech Due Diligence Provides new technology assessment and due diligence to support portfolio decisions, program prioritization, and partnerships for novel delivery platforms and medical devices.

Therapeutic Focus Seeks opportunities in small molecules, biotechnology products, immunotherapies, and novel delivery technologies, and can serve as a strategic clinical development partner for biotech firms.

Strategic Partnerships Acts as a high-level advisory and regulatory lead that can partner with larger CROs or device firms on subcontracted engagements, enabling rapid scaling without significant headcount.